Clinical HIV and AIDS Journal is a peer review, open access journal which covers topics from molecular biology to clinical studies and outcomes research, focusing on developments in novel therapeutics, prevention science, immune-restorative approaches and latest developments in treatment of sexually transmitted diseases.
This journal publishes empirical studies which promotes understanding of behavioral principles, physical health and illness and also provides international venue for scientific exchange of information on the psychosocial aspects of AIDS, Neurobehavioral factors, theoretical models of AIDS education which includes implementation, evaluation, and human retrovirology from all relevant basic and clinical sciences.
Boffin Access Clinical HIV and AIDS Journal encourages not plagiarized, genuine, innovative, original submissions of research articles, mini-reviews, editorials, short communications, case reports on latest progress and research advances through clinical trials, and examination of targeted antiretroviral agents which leads to improve in translational medicine for optimum treatment outcomes.
Clinical HIV and AIDS Journal, is an important and reliable source of current information on experimental, therapeutical, clinical, vaccines, pathogenesis, diagnostics, drug resistance, and virology of HIV/AIDS. This journal aims to provide forum for HIV/AIDS researchers, molecular biologists, infectious disease specialists, pathologists, virologists, epidemiologists, molecular geneticists, and microbiologists, and other professionals to find more advances in the area of HIV/AIDS research, antiviral treatment, viral immunology, clinical manifestations, HIV and sexual risk behaviours amongst intravenous drug users.